Supreme Court Urges SEBI to Close Sterling Biotech Case or Face Action
New Delhi, April 2 – The Supreme Court has directed the Securities and Exchange Board of India (SEBI) to either conclude its proceedings against Sterling Biotech Limited (SBL) and its promoters, Chetan and Nitin Sandesara, or face a detailed order from the bench.
SEBI Order and Deposit Requirement
The court, comprising Justices J K Maheshwari and A S Chandurkar, reiterated that all proceedings, including those initiated by SEBI, must be quashed if the Sandesara brothers deposit Rs 5,100 crore in the apex court registry. This order, issued last November, was contingent on the full and final settlement of claims.
Timeline of Events
The Sandesara brothers agreed to...